Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
Xuexiang Han(University of Pennsylvania), Mohamad‐Gabriel Alameh(George Mason University), Kamila Butowska(Gdańsk Medical University), James J. Knox(University of Pennsylvania), Kendall A. Lundgreen(University of Pennsylvania), Majed Ghattas(Polytechnique Montréal), Ningqiang Gong(University of Pennsylvania), Lulu Xue(University of Pennsylvania), Ying Xu(Case Western Reserve University), Marc Lavertu(Polytechnique Montréal), Paul Bates(University of Pennsylvania), Junchao Xu(National Center for Nanoscience and Technology), Guangjun Nie(National Center for Nanoscience and Technology), Yi Zhong(Peking University), Drew Weissman(University of Pennsylvania), Michael J. Mitchell(California Institute for Regenerative Medicine)
Cited by 226Open Access